I agree that this site is using cookies. You can find further informations here.
X
Faderl, Stefan
415  results:
Search for persons X
?
1

CPX-351 Pharmacokinetics and Safety in Adults with Hematolo..:

Solomon, Scott R. ; Powell, Bayard L. ; Koprivnikar, Jamie...
Cancers.  16 (2024)  5 - p. 915 , 2024
Link: https://doi.org/10.3390/..
 
?
2

P516: CARDIOTOXICITY OF CPX-351 VS 7 + 3 IN PATIENTS WITH U..:

Mitchell, Joshua D. ; Pfeiffer, Michael ; Boehmer, John...
HemaSphere.  7 (2023)  S3 - p. e178806c , 2023
Link: https://doi.org/10.1097/..
 
?
3

Efficacy and safety of CPX-351 versus 7 + 3 chemotherapy by..:

Cortes, Jorge E. ; Lin, Tara L. ; Asubonteng, Kobby...
Journal of Hematology & Oncology.  15 (2022)  1 - p. , 2022
Link: https://doi.org/10.1186/..
 
?
4

Transplant outcomes after CPX-351 vs 7 + 3 in older adults ..:

Uy, Geoffrey L. ; Newell, Laura F. ; Lin, Tara L....
Blood Advances.  6 (2022)  17 - p. 4989-4993 , 2022
Link: https://doi.org/10.1182/..
 
?
5

Preliminary Results By Age Group of Treatment with CPX-351 ..:

Pullarkat, Vinod ; Levis, Mark J. ; Mannis, Gabriel N....
Transplantation and Cellular Therapy.  28 (2022)  3 - p. S125 , 2022
Link: https://doi.org/10.1016/..
 
?
6

Frequency of infusion-related reactions with CPX-351 treatm..:

Jacoby, Meagan A. ; Finn, Laura ; Emadi, Ashkan...
Leukemia & Lymphoma.  62 (2021)  10 - p. 2539-2542 , 2021
Link: https://doi.org/10.1080/..
 
?
7

Quality-adjusted Time Without Symptoms of disease or Toxici..:

Cortes, Jorge E. ; Lin, Tara L. ; Uy, Geoffrey L....
Journal of Hematology & Oncology.  14 (2021)  1 - p. , 2021
Link: https://doi.org/10.1186/..
 
?
8

Five-Year Final Results of a Phase 3 Study of CPX-351 Versu..:

Cortes, Jorge E. ; Hogge, Donna E. ; Solomon, Scott R....
Transplantation and Cellular Therapy.  27 (2021)  3 - p. S126-S127 , 2021
Link: https://doi.org/10.1016/..
 
?
9

Long-Term Outcomes of Allogeneic Hematopoietic Cell Transpl..:

Uy, Geoffrey L. ; Newell, Laura F. ; Goldberg, Stuart L...
Transplantation and Cellular Therapy.  27 (2021)  3 - p. S58-S60 , 2021
Link: https://doi.org/10.1016/..
 
?
10

Older adults with newly diagnosed high-risk/secondary AML w..:

Lin, Tara L. ; Rizzieri, David A. ; Ryan, Daniel H....
Blood Advances.  5 (2021)  6 - p. 1719-1728 , 2021
Link: https://doi.org/10.1182/..
 
?
11

Outcomes in Patients with Therapy-Related Acute Myeloid Leu..:

Rizzieri, David A ; Schiller, Gary J. ; Solomon, Scott R....
Biology of Blood and Marrow Transplantation.  26 (2020)  3 - p. S105-S106 , 2020
Link: https://doi.org/10.1016/..
 
?
12

Efficacy and Safety of CPX-351 Versus 7+3 in a Phase 3 Expl..:

Lin, Tara ; Ryan, Daniel H. ; Ritchie, Ellen K....
Biology of Blood and Marrow Transplantation.  26 (2020)  3 - p. S102 , 2020
Link: https://doi.org/10.1016/..
 
?
13

Phase 1 study of CWP232291 in patients with relapsed or ref..:

Cortes, Jorge E. ; Kim, Minkyoung ; Lee, Kyoungjune...
Blood Advances.  4 (2020)  9 - p. 2032-2043 , 2020
Link: https://doi.org/10.1182/..
 
?
14

Outcomes in Patients with Acute Myeloid Leukemia with Myelo..:

Ryan, Daniel H. ; Newell, Laura F. ; Ritchie, Ellen K....
Biology of Blood and Marrow Transplantation.  26 (2020)  3 - p. S9-S10 , 2020
Link: https://doi.org/10.1016/..
 
?
15

Limitations to Receiving Allogeneic Hematopoietic Cell Tran..:

Sorror, Mohamed L. ; Storer, Barry E. ; Gerds, Aaron T....
Biology of Blood and Marrow Transplantation.  25 (2019)  3 - p. S115-S116 , 2019
Link: https://doi.org/10.1016/..
 
1-15